Gyre Therapeutics (GYRE) Amortizatization of Intangibles (2010 - 2015)
Gyre Therapeutics (GYRE) reported Amortizatization of Intangibles of $63000.0 for Q2 2015, down 72.12% year-over-year from $226000.0 in Q2 2014, and down 35.05% quarter-over-quarter from $97000.0 in Q1 2015.
Gyre Therapeutics (GYRE) Amortizatization of Intangibles (2010 - 2015) Analysis & Trends
Gyre Therapeutics (GYRE) has 6 years of Amortizatization of Intangibles data on file, last reported at $63000.0 in Q2 2015.
- Amortizatization of Intangibles for Q2 2015 came in at $63000.0, down 72.12% year-over-year; the trailing twelve-month figure through Jun 2015 was $484000.0 (down 41.62% YoY), and the FY2014 annual result was $775000.0, down 14.65% from the prior year.
- Amortizatization of Intangibles slipped to $63000.0 in Q2 2015 per GYRE's latest filing, from $97000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $335000.0 in Q3 2011 and troughed at $63000.0 in Q2 2015.
- A 5-year average of $205055.6 and a median of $225500.0 in 2013 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2011 and 2015: Amortizatization of Intangibles surged 125.0% in 2011, then slumped 72.12% in 2015.
- A 5-year view of Amortizatization of Intangibles shows it stood at $270000.0 in 2011, then declined by 23.33% to $207000.0 in 2012, then gained by 10.14% to $228000.0 in 2013, then sank by 37.72% to $142000.0 in 2014, then slumped by 55.63% to $63000.0 in 2015.
- Business Quant data shows GYRE's Amortizatization of Intangibles at $63000.0 in Q2 2015, $97000.0 in Q1 2015, and $142000.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Gyre Therapeutics | 554.75 Mn | 540.62 Mn | 8.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 63,000.00 |
| Jun 30, 2015 | 63,000.00 |
| Mar 31, 2015 | 97,000.00 |
| Mar 31, 2015 | 97,000.00 |
| Dec 31, 2014 | 142,000.00 |
| Dec 31, 2014 | 142,000.00 |
| Sep 30, 2014 | 182,000.00 |
| Sep 30, 2014 | 182,000.00 |
| Jun 30, 2014 | 226,000.00 |
| Jun 30, 2014 | 226,000.00 |
| Mar 31, 2014 | 225,000.00 |
| Mar 31, 2014 | 225,000.00 |
| Dec 31, 2013 | 228,000.00 |
| Dec 31, 2013 | 228,000.00 |
| Sep 30, 2013 | 150,000.00 |
| Sep 30, 2013 | 150,000.00 |
| Jun 30, 2013 | 304,000.00 |
| Jun 30, 2013 | 304,000.00 |
| Mar 31, 2013 | 226,000.00 |
| Mar 31, 2013 | 226,000.00 |